| Autor: |
Broberg M; Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland.; Institute for Molecular Medicine Finland, HiLIFE, University of Helsinki, 00290 Helsinki, Finland., Hästbacka J; New Children's Hospital, and Pediatric Research Center, Department of Anesthesia and Intensive Care, Helsinki University Hospital, 00290 Helsinki, Finland., Helle E; Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland.; New Children's Hospital, and Pediatric Research Center, Department of Pediatrics, Helsinki University Hospital, 00290 Helsinki, Finland. |
| Abstrakt: |
Congenital heart defects (CHD) are developmental malformations affecting the heart and the great vessels. Early heart development requires temporally regulated crosstalk between multiple cell types, signaling pathways, and mechanical forces of early blood flow. While both genetic and environmental factors have been recognized to be involved, identifying causal genes in non-syndromic CHD has been difficult. While variants following Mendelian inheritance have been identified by linkage analysis in a few families with multiple affected members, the inheritance pattern in most familial cases is complex, with reduced penetrance and variable expressivity. Furthermore, most non-syndromic CHD are sporadic. Improved sequencing technologies and large biobank collections have enabled genome-wide association studies (GWAS) in non-syndromic CHD. The ability to generate human to create human induced pluripotent stem cells (hiPSC) and further differentiate them to organotypic cells enables further exploration of genotype-phenotype correlations in patient-derived cells. Here we review how these technologies can be used in unraveling the genetics and molecular mechanisms of heart development. |
